API Innovation Center

We're #hiring a new Director, Lab Operations in St Louis, Missouri. Apply today or share this post with your network.

National drug shortages continue to affect millions of Americans, including those in St. Louis, as highlighted in KMOV-TV’s recent story. The API Innovation Center is committed to solving this crisis by building resilience in the U.S. pharmaceutical supply chain through advanced manufacturing technologies and strategic public-private partnerships. By focusing on domestic production of critical medications, we’re working to reduce dependence on foreign suppliers and eliminate vulnerabilities in the pharmaceutical supply chain. Backed by federal and state support, our efforts aim to create scalable, sustainable solutions while generating jobs and fostering innovation right here in St. Louis. This journey will take time, but we are steadfast in our mission to strengthen our nation’s health security. Together with our partners, we are paving the way for a more resilient pharmaceutical future. Check out the full story and interview with KMOV on our website: https://lnkd.in/e9RhDAE7 Correction at 6:35 in the tape, APIIC is not developing a medication for ADHD. #DrugShortage #SupplyChainResilience #APIInnovationCenter #AdvancedManufacturing #HealthSecurity

We're #hiring a new Government Contract Reporting Specialist in St Louis, Missouri. Apply today or share this post with your network.

We ended our “A Bold Goal: Pathway to Build U.S. Drug Supply Chain Resilience” plenary event on a high note. We enjoyed great presentations from Betsy Baer at US Pharmacopeia and Josh Narrow from The Conafay Group this afternoon. Huge thanks to our panelists from our Public-Private Partnerships and Collaboration discussion: -Betsy Baer | US Pharmacopeia -Vadim J. Gurvich, Ph.D., M.B.A. | National Institute for Pharmaceutical Technology & Education (NIPTE) -Kristy Hawkins | Antheia, Inc. -Josh Marion, MBA | ATI | Advanced Technology International And to the panelists on our final panel, Regulatory and Policy Considerations: -Joe Hill | US Pharmacopeia -Gerren McHam | API Innovation Center -Josh Narrow | The Conafay Group -Victor Suarez | Blu Zone Bioscience & Supply Chain Solutions, LLC -Marta E. Wosinska, Ph.D. | The Brookings Institution This event was a success thanks to your support and involvement! We look forward to continuing this discussion and sharing our recommendations for building drug supply chain resiliency in our upcoming white paper.

We're starting our “A Bold Goal: Pathway to Build U.S. Drug Supply Chain Resilience” plenary event off strong! We had some fantastic presentations from Tamara F. at PharmaACE and Anthony Sardella from API Innovation Center this morning. Huge thanks to our panelists from our Designing a Sustainable Long-Term Drug Supply Chain discussion: -Michael Ganio | ASHP -Andrew Gonce | PharmD -Monique K. Mansoura, PhD, MBA | MITRE -Aaron Willard | API Innovation Center And to the panelists on our second panel, Understanding AMTs for Domestic API Manufacturing: -Jason Rodriguez | FDA -Omar Rana | MilliporeSigma -Bayan Takizawa | CONTINUUS Pharmaceuticals -Jeremy West | Corning Incorporated. You can still join us virtually for our afternoon session's on public-private partnerships and regulatory and policy considerations. Registration for the virtual event is open on our website: https://lnkd.in/e5zMhnww

The API Innovation Center's 2nd Annual Plenary Event, “A Bold Goal: Pathway to Build U.S. Drug Supply Chain Resilience,” is only a day away! We’re bringing together industry leaders, government partners and subject matter experts to explore how we can strengthen the U.S. pharmaceutical supply chain through collaboration and innovation. Curious about what’s on the agenda? The schedule below outlines our full lineup of panels and presentations. We look forward to seeing you very soon! It's not too late to join us virtually. Register here: https://lnkd.in/e5zMhnww #SupplyChainResilience #PharmaceuticalManufacturing #APIInnovationCenter #PublicPrivatePartnerships

The National Science Foundation (NSF) has invited the API Innovation Center (APIIC) to submit a full proposal to the NSF Regional Innovation Engines program for up to $160 million in funding over 10 years. This opportunity underscores NSF’s recognition of our work to address national drug shortages and bolster health security by reshoring key starting materials (KSMs) and active pharmaceutical ingredients (APIs) with new API chemical pathways and innovative technologies. APIIC’s proposal, "Reshoring KSM and API Manufacturing Through Innovation," was one of 71 selected from 250 submissions, and we’re excited to move forward. Our proposal, developed in collaboration with over 30 organizations across diverse strategic workgroup pillars, aims to boost the regional economy, create high-quality jobs and build a resilient domestic supply of essential medications to strengthen national health security. With the continued support of our incredible collaborators, APIIC is ready to make a lasting impact on the Missouri region and the nation’s pharmaceutical resilience. Read more about the announcement here: https://lnkd.in/exqgGjDG #APIInnovation #HealthSecurity #EconomicGrowth #SupplyChainResilience #NationalScienceFoundation #FutureTech

This week,?the API Innovation Center joined the BioMaP-Consortium | Biopharmaceutical Manufacturing Preparedness Consortium's Industry Day as part of their Fireside Chat with BioMaP-Consortium 2024 Awardees. Special thanks to Biomedical Advanced Research and Development Authority (BARDA), ATI | Advanced Technology International and everyone else that helped organize this fantastic event as well as Betsy Baer for this great picture! We look forward to engaging with other members of the consortium and shaping the future of biopharmaceutical manufacturing together. #SupplyChainResilience #PharmaceuticalManufacturing #APIInnovation #HealthSecurity #BioMaP

We’re just two weeks away from the API Innovation Center’s 2nd annual plenary event, "A Bold Goal: Pathway to Build U.S. Drug Supply Chain Resilience," hosted at Washington University's Charles F. Knight Center in St. Louis on November 13, 2024! Join us for a gathering of stakeholders, industry leaders, and subject matter experts who are committed to strengthening the U.S. drug supply chain. We look forward to expanding on our discussions from last year's plenary event. Take a look at the key themes that our panel discussions will cover: - Designing a Sustainable, Long-Term Drug Supply Chain: Strategies for building a resilient drug supply chains. - Advanced Manufacturing Technologies for Domestic API Production: How innovative technology is shaping the future of API manufacturing. - Public-Private Partnerships and Collaboration: The importance of strengthening collaboration across sectors to build a stronger pharmaceutical industry. - Regulatory Affairs and Policy Considerations: Navigating policies to support supply chain resilience. If you haven't registered yet, there's still time! RSVP here: https://lnkd.in/e5zMhnww. We are also offering a virtual option for those who can’t make it in person. If you are traveling for our event and need to make accommodations, a hotel block has been reserved for guests of the conference at the Charles F. Knight Center. Please reach out to us at [email protected] for more information on how to reserve your room as part of this hotel block. #SupplyChainResilience #PharmaceuticalManufacturing #APIInnovation #HealthSecurity #EconomicGrowth #FutureTech

How can we keep St. Louis’ brightest students here after graduation? It’s a question we explored alongside Washington University’s Olin Business School and the Center for Analytics and Business Insights (CABI) at their Data for Good: Attracting and Retaining Talent in St. Louis conference. The API Innovation Center was invited to join with local leaders and innovators to discuss takeaways from CABI's new research and ideas for carrying it forward. CABI's report, "In St. Louis for St. Louis: A Data-Driven Approach For Attracting & Retaining Talent," identifies the top factors influencing students' relocation decisions—like salary, advancement opportunities, company reputation, proximity to family and friends, cost of living, safety, and climate. With tools that predict how these factors impact these decisions, St. Louis is more prepared than ever to support students in choosing to stay and build their futures here. By leveraging our region’s strengths—whether in life sciences, health, or pharmaceutical manufacturing—St. Louis is creating high-quality, impactful job opportunities that are attractive to new grads. At the API Innovation Center, we’re committed to advancing the pharmaceutical industry in Missouri to help create well-paid jobs and ensure economic growth in the region. Read the full article to see how we are working with other key stakeholders to make our city a destination for top talent to thrive: https://lnkd.in/e6Y6r6gH